サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1339213

カルボキシセラピー市場、シェア、規模、動向、産業分析レポート：製品タイプ別；最終用途別；およびセグメント別予測、2023年～2032年

Carboxy Therapy Market Share, Size, Trends, Industry Analysis Report, By Product Type (Table Top, Portable); By End-use (Hospitals, Aesthetic Clinics, Medspa); And Segment Forecasts, 2023 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 115 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.98円
カルボキシセラピー市場、シェア、規模、動向、産業分析レポート：製品タイプ別；最終用途別；およびセグメント別予測、2023年～2032年
出版日: 2023年07月23日
発行: Polaris Market Research
ページ情報: 英文 115 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界のカルボキシセラピー市場規模は2032年までに1億849万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

非侵襲的な処置に対する意識の高まりは、世界中でそのような処置の需要を促進すると予想されます。カルボキシセラピーの主な用途の一つはセルライトの治療です。二酸化炭素を注入することで、血液循環を改善し、リンパの流れを促進し、コラーゲンの生成を促し、セルライトの見た目の減少につながります。このため、カルボキシセラピーは、この一般的な美容上の悩みに対処しようとする人々にとって魅力的な選択肢となっています。

セルライトに加え、カルボキシセラピーはシワなど他の美容的問題にも使用されます。炭酸ガスのイントロダクションは、コラーゲンとエラスチンの生成を刺激し、肌の弾力性を維持し、シワを目立たなくするために不可欠な成分です。肌の若返りと引き締めを促進することで、カルボキシセラピーは、より若々しくリフレッシュした外見を実現するのに役立ちます。目の下のクマも、カルボキシセラピーで治療することができます。二酸化炭素を注入することにより血流と酸素が増加し、クマが目立たなくなり、目の下が明るくなります。

非外科的かつ低侵襲の美容整形に対する需要が、特に高齢化社会の間で高まっていることが、カルボキシセラピー市場の大きな促進要因となっています。加齢の兆候に対処し、外見を改善するための効果的な解決策を求める個人にとって、カルボキシセラピーのような非外科的選択肢は、ダウンタイムが短く、リスクが少なく、自然な仕上がりといった魅力的なメリットを提供します。

さらに、肌の質感を改善するカルボキシセラピーの利点に対する認識が高まっていることも、市場の成長に寄与しています。コラーゲン産生を刺激し、血液循環を改善し、肌の色調や質感を向上させる能力など、この施術の潜在的な利点を知る人が増えるにつれて、カルボキシセラピーの需要は増加します。

国際美容形成外科学会の2021年版報告書によると、世界における顔面・頭部外科手術の件数は顕著に増加しています。これらの手術は前年から約14.8％の成長率を記録し、世界全体で合計5,211,933件に達しました。さらに、顔面および頭部の外科手術は、実施された外科手術の総数の約40.59％を占めています。その結果、カルボキシセラピー市場は今後数年間で大きく成長する見込みです。

カルボキシセラピー市場レポートハイライト

2022年の市場シェアはテーブルトップ型が最も高かったです。

美容クリニックの嗜好の高まりと費用対効果により、美容クリニックセグメントが2022年に最大市場収益シェアを占めました。

北米地域が世界市場を席巻、これは老年人口の増加と低侵襲処置の嗜好の高まりによる。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のカルボキシセラピー市場に関する洞察

  • カルボキシセラピー市場- 業界スナップショット
  • カルボキシセラピー市場力学
    • 促進要因と機会
      • ポータブルデバイスの認知度の向上と可用性が市場の成長を促進
      • 世界的に美容整形手術が増加
    • 抑制要因と課題
      • 規制政策と安全性への懸念
  • PESTLE分析
  • カルボキシセラピー業界の動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界のカルボキシセラピー市場、製品タイプ別

  • 主な調査結果
  • イントロダクション
  • テーブルトップ
  • ポータブル

第6章 世界のカルボキシセラピー市場、最終用途別

  • 主な調査結果
  • イントロダクション
  • 病院
  • エステティッククリニック
  • メドスパ

第7章 世界のカルボキシセラピー市場、地域別

  • 主な調査結果
  • イントロダクション
    • カルボキシセラピー市場評価、地域別、2019-2032年
  • カルボキシセラピー市場-北米
    • 北米：カルボキシセラピー市場、最終用途別、2019-2032年
    • 北米：カルボキシセラピー市場、製品タイプ別、2019-2032年
    • カルボキシセラピー市場-米国
    • カルボキシセラピー市場- カナダ
  • カルボキシセラピー市場- 欧州
    • 欧州：カルボキシセラピー市場、最終用途別、2019～2032年
    • 欧州：カルボキシセラピー市場、製品タイプ別、2019～2032年
    • カルボキシセラピー市場- 英国
    • カルボキシセラピー市場- フランス
    • カルボキシセラピー市場- ドイツ
    • カルボキシセラピー市場- イタリア
    • カルボキシセラピー市場- スペイン
    • カルボキシセラピー市場- オランダ
    • カルボキシセラピー市場- ロシア
  • カルボキシセラピー市場- アジア太平洋
    • アジア太平洋：カルボキシセラピー市場、最終用途別、2019～2032年
    • アジア太平洋：カルボキシセラピー市場、製品タイプ別、2019～2032年
    • カルボキシセラピー市場- 中国
    • カルボキシセラピー市場- インド
    • カルボキシセラピー市場- マレーシア
    • カルボキシセラピー市場- 日本
    • カルボキシセラピー市場- インドネシア
    • カルボキシセラピー市場- 韓国
  • カルボキシセラピー市場-中東およびアフリカ
    • 中東およびアフリカ：カルボキシセラピー市場、最終用途別、2019～2032年
    • 中東およびアフリカ：カルボキシセラピー市場、製品タイプ別、2019～2032年
    • カルボキシセラピー市場- サウジアラビア
    • カルボキシセラピー市場- アラブ首長国連邦
    • カルボキシセラピー市場- イスラエル
    • カルボキシセラピー市場- 南アフリカ
  • カルボキシセラピー市場-ラテンアメリカ
    • ラテンアメリカ：カルボキシセラピー市場、最終用途別、2019-2032年
    • ラテンアメリカ：カルボキシセラピー市場、製品タイプ別、2019-2032年
    • カルボキシセラピー市場- メキシコ
    • カルボキシセラピー市場- ブラジル
    • カルボキシセラピー市場- アルゼンチン

第8章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第9章 企業プロファイル

  • DTA Medical
  • Mezopharma
  • MBE Medical Divisons
  • Alvi Prague
  • Kastner-Praxisbedarf
  • Beijing Jontelaser
  • Cosmopro
  • Carbossiterapia Italiana
  • MEDAiON Plasma
図表

List of Tables

  • Table 1 Global Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 2 Global Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 3 Carboxy Therapy Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 4 North America: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 5 North America: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 6 U.S.: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 7 U.S.: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 8 Canada: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 9 Canada: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 10 Europe: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 11 Europe: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 12 UK: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 13 UK: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 14 France: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 15 France: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 16 Germany: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 17 Germany: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 18 Italy: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 19 Italy: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 20 Spain: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 21 Spain: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 22 Netherlands: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 23 Netherlands: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 24 Russia: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 25 Russia: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 26 Asia Pacific: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 27 Asia Pacific: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 28 China: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 29 China: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 30 India: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 31 India: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 32 Malaysia: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 33 Malaysia: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 34 Japan: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 35 Japan: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 36 Indonesia: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 37 Indonesia: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 38 South Korea: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 39 South Korea: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 40 Middle East & Africa: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 41 Middle East & Africa: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 42 Saudi Arabia: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 43 Saudi Arabia: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 44 UAE: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 45 UAE: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 46 Israel: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 47 Israel: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 48 South Africa: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 49 South Africa: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 50 Latin America: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 51 Latin America: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 52 Mexico: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 53 Mexico: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 54 Brazil: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 55 Brazil: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • Table 56 Argentina: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • Table 57 Argentina: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)

List of Figures

  • Figure 1 Global Carboxy Therapy Market, 2019-2032 (USD Million)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by End Use
  • Figure 7 Global Carboxy Therapy Market, by End Use, 2022 & 2032 (USD Million)
  • Figure 8 Market by Product Type
  • Figure 9 Global Carboxy Therapy Market, by Product Type, 2022 & 2032 (USD Million)
  • Figure 10 Carboxy Therapy Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 11 Strategic Analysis - Carboxy Therapy Market
目次
Product Code: PM3593

The global carboxy therapy market size is expected to reach USD 108.49 million by 2032, according to a new study by Polaris Market Research. The report "Carboxy Therapy Market Share, Size, Trends, Industry Analysis Report, By Product Type (Table Top, Portable); By End-use (Hospitals, Aesthetic Clinics, Medspa); And Segment Forecasts, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rising awareness of the non-invasive procedures are expected to drive the demand for such procedures across the globe. One of the primary applications of carboxy therapy is in the treatment of cellulite. The injection of carbon dioxide helps to improve blood circulation, promote lymphatic drainage, and stimulate collagen production, which can lead to a reduction in the appearance of cellulite. This makes carboxy therapy an attractive option for individuals seeking to address this common aesthetic concern.

In addition to cellulite, carboxy therapy is also used to target other cosmetic issues such as wrinkles. The introduction of carbon dioxide gas stimulates the production of collagen and elastin, which are essential components for maintaining skin elasticity and reducing the appearance of wrinkles. By promoting skin rejuvenation and tightening, carboxy therapy can help individuals achieve a more youthful and refreshed appearance. Under-eye dark circles, another common concern, can also be treated with carboxy therapy. The increased blood flow and oxygenation resulting from the injection of carbon dioxide can improve the appearance of dark circles, reducing their visibility and brightening the under-eye area.

The growing demand for non-surgical and minimally invasive cosmetic procedures, particularly among the aging population, is a significant driver of the carboxy therapy market. As individuals seek effective solutions to address signs of aging and improve their appearance, non-surgical options like carboxy therapy offer attractive benefits such as minimal downtime, fewer risks, and natural-looking results.

Furthermore, the increasing awareness of the advantages of carboxy therapy for improving skin texture contributes to market growth. As more people become aware of the potential benefits of this procedure, including its ability to stimulate collagen production, improve blood circulation, and enhance skin tone and texture, the demand for carboxy therapy increases.

The International Society of Aesthetic Plastic Surgery's 2021 report indicates a notable increase in the number of face and head surgical procedures worldwide. These procedures experienced a growth rate of approximately 14.8% from the previous year, reaching a total of 5,211,933 procedures globally. Additionally, face and head surgical procedures account for approximately 40.59% of the total number of surgical procedures performed. As a result, the carboxy therapy market is poised to experience substantial growth in the coming years.

Carboxy Therapy Market Report Highlights

Table top segment accounted for highest market share in 2022, due to high availability of such devices in the aesthetic clinics

Aesthetic clinics segment held the maximum market revenue share in 2022, due to growing preference of aesthetic clinics & its cost effectiveness

North America region dominated the global market, owing to rise in geriatrics and rise in preference of minimally invasive procedures

The global key market players include: DTA Medical, Mezopharma, MBE Medical Divisons, Alvi Prague, Kastner-Praxisbedarf, Beijing Jontelaser, Cosmopro, Carbossiterapia Italiana, and MEDAiON Plasma.

Polaris Market Research has segmented the carboxy therapy market report based on product type, end-use, and region:

Carboxy Therapy, Product Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Table Top
  • Portable

Carboxy Therapy, End-Use Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals
  • Aesthetic Clinics
  • Medspa

Carboxy Therapy, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Carboxy Therapy Market Insights

  • 4.1. Carboxy Therapy Market - Industry Snapshot
  • 4.2. Carboxy Therapy Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising awareness and availability of portable devices are fueling market growth
      • 4.2.1.2. Increasing aesthetic plastic surgery globally
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Regulatory policies and safety concern
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Carboxy Therapy Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Carboxy Therapy Market, by Product Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Carboxy Therapy, by Product Type, 2019-2032 (USD Million)
  • 5.3. Table Top
    • 5.3.1. Global Carboxy Therapy Market, by Table Top, by Region, 2019-2032 (USD Million)
  • 5.4. Portable
    • 5.4.1. Global Carboxy Therapy Market, by Portable, by Region, 2019-2032 (USD Million)

6. Global Carboxy Therapy Market, by End Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Global Carboxy Therapy Market, by Hospitals, by Region, 2019-2032 (USD Million)
  • 6.4. Aesthetic Clinics
    • 6.4.1. Global Carboxy Therapy Market, by Aesthetic Clinics, by Region, 2019-2032 (USD Million)
  • 6.5. Medspa
    • 6.5.1. Global Carboxy Therapy Market, by Medspa, by Region, 2019-2032 (USD Million)

7. Global Carboxy Therapy Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Carboxy Therapy Market Assessment, By Geography, 2019-2032 (USD Million)
  • 7.3. Carboxy Therapy Market - North America
    • 7.3.1. North America: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
    • 7.3.2. North America: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
    • 7.3.3. Carboxy Therapy Market - U.S.
      • 7.3.3.1. U.S.: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
      • 7.3.3.2. U.S.: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
    • 7.3.4. Carboxy Therapy Market - Canada
      • 7.3.4.1. Canada: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
      • 7.3.4.2. Canada: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • 7.4. Carboxy Therapy Market - Europe
    • 7.4.1. Europe: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
    • 7.4.2. Europe: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
    • 7.4.3. Carboxy Therapy Market - UK
      • 7.4.3.1. UK: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
      • 7.4.3.2. UK: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
    • 7.4.4. Carboxy Therapy Market - France
      • 7.4.4.1. France: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
      • 7.4.4.2. France: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
    • 7.4.5. Carboxy Therapy Market - Germany
      • 7.4.5.1. Germany: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
      • 7.4.5.2. Germany: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
    • 7.4.6. Carboxy Therapy Market - Italy
      • 7.4.6.1. Italy: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
      • 7.4.6.2. Italy: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
    • 7.4.7. Carboxy Therapy Market - Spain
      • 7.4.7.1. Spain: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
      • 7.4.7.2. Spain: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
    • 7.4.8. Carboxy Therapy Market - Netherlands
      • 7.4.8.1. Netherlands: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
      • 7.4.8.2. Netherlands: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
    • 7.4.9. Carboxy Therapy Market - Russia
      • 7.4.9.1. Russia: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
      • 7.4.9.2. Russia: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • 7.5. Carboxy Therapy Market - Asia Pacific
    • 7.5.1. Asia Pacific: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
    • 7.5.2. Asia Pacific: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
    • 7.5.3. Carboxy Therapy Market - China
      • 7.5.3.1. China: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
      • 7.5.3.2. China: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
    • 7.5.4. Carboxy Therapy Market - India
      • 7.5.4.1. India: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
      • 7.5.4.2. India: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
    • 7.5.5. Carboxy Therapy Market - Malaysia
      • 7.5.5.1. Malaysia: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
      • 7.5.5.2. Malaysia: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
    • 7.5.6. Carboxy Therapy Market - Japan
      • 7.5.6.1. Japan: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
      • 7.5.6.2. Japan: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
    • 7.5.7. Carboxy Therapy Market - Indonesia
      • 7.5.7.1. Indonesia: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
      • 7.5.7.2. Indonesia: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
    • 7.5.8. Carboxy Therapy Market - South Korea
      • 7.5.8.1. South Korea: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
      • 7.5.8.2. South Korea: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • 7.6. Carboxy Therapy Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
    • 7.6.2. Middle East & Africa: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
    • 7.6.3. Carboxy Therapy Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
      • 7.6.3.2. Saudi Arabia: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
    • 7.6.4. Carboxy Therapy Market - UAE
      • 7.6.4.1. UAE: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
      • 7.6.4.2. UAE: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
    • 7.6.5. Carboxy Therapy Market - Israel
      • 7.6.5.1. Israel: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
      • 7.6.5.2. Israel: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
    • 7.6.6. Carboxy Therapy Market - South Africa
      • 7.6.6.1. South Africa: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
      • 7.6.6.2. South Africa: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
  • 7.7. Carboxy Therapy Market - Latin America
    • 7.7.1. Latin America: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
    • 7.7.2. Latin America: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
    • 7.7.3. Carboxy Therapy Market - Mexico
      • 7.7.3.1. Mexico: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
      • 7.7.3.2. Mexico: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
    • 7.7.4. Carboxy Therapy Market - Brazil
      • 7.7.4.1. Brazil: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
      • 7.7.4.2. Brazil: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)
    • 7.7.5. Carboxy Therapy Market - Argentina
      • 7.7.5.1. Argentina: Carboxy Therapy Market, by End Use, 2019-2032 (USD Million)
      • 7.7.5.2. Argentina: Carboxy Therapy Market, by Product Type, 2019-2032 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. DTA Medical
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Mezopharma
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. MBE Medical Divisons
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Alvi Prague
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Kastner-Praxisbedarf
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Beijing Jontelaser
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Cosmopro
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Carbossiterapia Italiana
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. MEDAiON Plasma
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development